CLASS II Device recall · Reported 24 Mar 2021 · FDA Enforcement Report

Vitros Immunodiagnostic Products Sars-CoV-2 Antigen recalled

Ortho-Clinical Diagnostics is recalling Vitros Immunodiagnostic Products Sars-CoV-2 Antigen Reagent- In Vitro Diagnostic, distributed nationwide in the US. The recall was initiated on 12 Feb 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAny lot used with Remel M4RT VTM UDI: 10758750033584
Quantity recalled2782 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1266-2021
FDA event ID
87356
Recalling firm
Ortho-Clinical Diagnostics, Rochester, NY
Classification
Class II
Status
Terminated
Recall initiated
12 Feb 2021
FDA classified
17 Mar 2021
Reported
24 Mar 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

12 Feb 2021Recall initiated by company
17 Mar 2021Classified by FDA+33 days
24 Mar 2021Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

VITROS Immunodiagnostic Products SARS-CoV-2 Antigen False Reactive Results Associated When Using Remel M4RT Viral Transport Media

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Reagent- In Vitro Diagnostic. The VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Reagent Pack when used in combination with the VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Calibrator is a chemiluminescent immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in nasopharyngeal (NP) specimens. . For emergency authorization use only (EAU). Intended for Use in the United States Product Code: 6199949.

Where it was distributed

Worldwide distribution - US Nationwide distribution and the countries of Australia, Belgium, Canada L3R 4G5, Chile, Colombia, Denmark, France, Germany, India, Italy, Japan, Portugal, Russia, Singapore 609917, Spain, United Kingdom.

Nationwide

Questions about this recall

Why was it recalled?

VITROS Immunodiagnostic Products SARS-CoV-2 Antigen False Reactive Results Associated When Using Remel M4RT Viral Transport Media

Which lots are affected?

Any lot used with Remel M4RT VTM UDI: 10758750033584

Where was it sold?

Worldwide distribution - US Nationwide distribution and the countries of Australia, Belgium, Canada L3R 4G5, Chile, Colombia, Denmark, France, Germany, India, Italy, Japan, Portugal, Russia, Singapore 609917, Spain, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 87356

This product is part of a recall event; the main page for the event is Vitros Sars-CoV-2 Antigen Reagent Pack recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIVitros Sars-CoV-2 Antigen Reagent Pack recalledOrtho-Clinical DiagnosticsPotency & AssayNationwide

More recalls from Ortho-Clinical Diagnostics

All 311

Other Test Kits & Diagnostics recalls

All 2,656